Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-029180
Filing Date
2009-12-15
Accepted
2009-12-15 16:11:27
Documents
1
Period of Report
2009-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3349
  Complete submission text file 0001140361-09-029180.txt   5187
Mailing Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 EAST 62ND STREET NEW YORK NY 10021
Business Address
SAVAS PAUL G (Reporting) CIK: 0001275756 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 091241877